When will the FDA approve Intellia Therapeutics' lonvo-z?
Lonvoguran Ziclumeran (lonvo-z) for Hereditary AngioedemaScience
When will the FDA approve Intellia Therapeutics' lonvo-z?
Lonvoguran Ziclumeran (lonvo-z) for Hereditary AngioedemaScience
Kalshi Active 3 markets·64¢ When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?·$0 Total Volume·-- Liquidity·-- OI
12mo·Jul 8, 2027
Track your prediction positions
Connect your Kalshi account to track your contracts, P&L, and settlements.
Wide spread
No chart data available
Markets
3Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
$0 vol
Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
$0 vol
Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
$0 vol
Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
No order book data available
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.
Track Your Bets on Kalshi — and Everything Else
Create a free portfolio starting with your Kalshi positions, P&L & live odds. Then add crypto wallets, exchanges, DeFi & more — all in one place.
Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% free· Read-only· Encrypted